"Feb. 1, 2012 -- A new drug appears to be effective for shrinking uterine fibroids and controlling the heavy menstrual bleeding they often cause, according to new research from Europe.
In one study, the drug ulipristal acetate proved t"...
DOSAGE AND ADMINISTRATION
Instruct patients to take one tablet orally as soon as possible within 120 hours (5 days) after unprotected intercourse or a known or suspected contraceptive failure.
The tablet can be taken with or without food.
If vomiting occurs within 3 hours of ella intake, consideration should be given to repeating the dose.
ella can be taken at any time during the menstrual cycle.
Dosage Forms And Strengths
The ella tablet is supplied as a white to off-white, round, curved tablet containing 30 mg of ulipristal acetate and is marked “ella” on both sides.
Storage And Handling
ella (ulipristal acetate) tablet, 30 mg is supplied in a PVC-PE-PVDC-aluminum blister. The tablet is a white to off-white, round, curved tablet marked with “ella” on both sides.
NDC 50102-911-01 (1 tablet unit of use package)
Store at 20-25°C (68-77°F). [See USP controlled room temperature.]
Keep the blister in the outer carton in order to protect from light. Keep out of reach of children.
Distributed By: Afaxys, Inc. Charleston, SC, 29403, USA. Under License From: Laboratoire HRA Pharma 75003 Paris, France ella® is a registered trademark of Laboratoire HRA Pharma. Manufactured by: Cenexi, 95520 Osny, France, or Laboratorios León Farma S.A., 24008 León, Spain or Delpharm Lille SAS, 59390 Lys-Lez-Lannoy, France, Content Updated: June 2014
Last reviewed on RxList: 6/30/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Ella Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.